The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes

Por Yun, Eun-Jin, Zhou, Jiancheng, Lin, Chun-Jung, Xu, Shan, Santoyo, John, Hernandez, Elizabeth, Lai, Chih-Ho, Lin, Ho, He, Dalin, Hsieh, Jer-Tsong
Publicado no Oncotarget (2017)

Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs

Por Zhou, Jiancheng, Yun, Eun-Jin, Chen, Wei, Ding, Ye, Wu, Kaijie, Wang, Bin, Ding, Chunyong, Hernandez, Elizabeth, Santoyo, John, Pong, Rey-Chen, Chen, Haiying, He, Dalin, Zhou, Jia, Hsieh, Jer-Tsong
Publicado no Cell Death Dis (2017)

Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues

Por Chen, Wei, Zhou, Jiancheng, Wu, Kaijie, Huang, Jun, Ding, Ye, Yun, Eun-Jin, Wang, Bin, Ding, Chunyong, Hernandez, Elizabeth, Santoyo, John, Chen, Haiying, Lin, Ho, Sagalowsky, Arthur, He, Dalin, Zhou, Jia, Hsieh, Jer-Tsong
Publicado no Oncotarget (2016)

KDM4/JMJD2 histone demethylase inhibitors block prostate tumor growth by suppressing the expression of AR and BMYB-regulated genes

Por Duan, Lingling, Rai, Ganesha, Roggero, Carlos, Zhang, Qing-Jun, Wei, Qun, Ma, Shi Hong, Zhou, Yunyun, Santoyo, John, Martinez, Elisabeth D., Xiao, Guanghua, Raj, Ganesh V., Jadhav, Ajit, Simeonov, Anton, Maloney, David J., Rizo, Josep, Hsieh, JT, Liu, Zhi-Ping
Publicado no Chem Biol (2015)